164PDoes patient selection according to RAS/PIK3CA/BRAF mutational status enrich the efficacy of adjuvant chemotherapy for Stage IV CRC after R0 resection?
Nakayama, I., Shinozaki, E., Azuma, T., Wakatsuki, T., Ogura, M., Ichimura, T., Ozaka, M., Takahari, D., Chin, K., Mizunuma, N.Volume:
26
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv523.25
Date:
December, 2015
Fichier:
PDF, 31 KB
english, 2015
File converter
Plus de résultats de recherche
More benefits 
